PARSIPPANY, N.J.--(BUSINESS WIRE)--April 19, 2006--The Medicines Company (NASDAQ: MDCO - News) today announced its financial results for the first quarter 2006. Glenn Sblendorio, Executive Vice President and Chief Financial Officer of The Medicines Company stated, “An increase in underlying demand for Angiomax in the U.S. enabled us to reduce wholesaler inventories to the target we guided in October of last year. This clears the way for our reported sales to be more consistent with end user demand. For the quarter, net sales in the U.S. were $32.8 million and other revenues were $1.8 million.”
